Bidirectional Mendelian randomization was used and a multi-trait analysis of GWAS was conducted. The team will now carry out an analysis of already trialed treatments at this potential intervention point. The FDA has approved tocilizumab-aazg for the treatment of rheumatoid arthritis, among other diseases. A case series presented data on the efficacy of CAR T-cell treatment in patients with rheumatic autoimmune disease. Having multiple risk factors for cardiovascular disease may increase the risk of rheumatoid arthritis treatment failure. Recent safety data significantly impacted prescribing practices for advanced RA therapies among physicians treating veterans. A study sought to identify variables distinguishing inflammatory from noninflammatory arthritis in a large cohort. Abatacept improved outcomes for rheumatoid arthritis refractory to methotrexate or TNFi versus rituximab or tocilizumab. Ultra-low dose rituximab significantly reduced the rate of infections versus the standard low dosage in rheumatoid arthritis. The American College of Rheumatology has released new recommendations for the management of rheumatoid arthritis. Patients with rheumatoid arthritis with lower hemoglobin levels may be more likely to have increased progression over time. Researchers established tranexamic acid was safe and effective in patients with rheumatoid arthritis following TKA. In a recent study, published in Rheumatology International, researchers sought to determine predictive variables for ... Telomere length shortening plays a role in the deterioration and death of various immune cells, leading to immune ... In the phase 4 AWARE study, researchers compared golimumab and infliximab in patients with rheumatoid arthritis. After ... Researchers, led by Gerd R Burmester, conducted a clinical trial to evaluate the long-term safety outcomes of ... Researchers sought to determine if immunomodulators and related combination therapy strategies reduced cardiovascular ... ABBV-3373, a novel antibody drug conjugate (ADC) for the treatment of rheumatoid arthritis, demonstrated similar ... In the ORAL Surveillance study, researchers found tofacitinib showed a higher incidence of pulmonary embolism compared ... In a recent meta-analysis, published in RMD Open, researchers sought to identify laboratory biomarkers that predicted ...